HLB Genex, Inc.

187420· KOSDAQ· Materials· Materials

₩1,735-2.31%

2026-09-18

Financials

Valuation Metrics

HLB Genex, Inc.'s Market Cap is ₩566B. At end of 2025 it was ₩865B. Ranked #1694 of 2,421 in KR market (top 70%), #1022 of 1,640 on KOSDAQ (top 62%), #200 of 294 in Materials (top 68%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	56.64B KRW	KR#1,694/2,421 Sec#200/294
Revenue	45.67B KRW	KR#1,840/2,421 Sec#260/294
Net Income	9.69B KRW	KR#983/2,421 Sec#114/294
Total Assets	138.05B KRW	KR#1,565/2,421 Sec#216/294
Net Assets	68.59B KRW	KR#1,695/2,421 Sec#231/294
Employees	70	KR#1,873/2,421 Sec#230/294
Value
P/E	5.85x	KR#440/2,421 Sec#53/294
P/B	0.83x	KR#1,293/2,421 Sec#212/294
PEG	0.02x	KR#176/2,421 Sec#23/294
P/S	1.24x	KR#1,517/2,421 Sec#248/294
EV/EBITDA	74.31x	KR#1,440/2,421 Sec#198/294
FCF Yield	4.73%	KR#865/2,421 Sec#105/294
Profitability
ROE	14.12%	KR#365/2,421 Sec#26/294
ROA	7.02%	KR#515/2,421 Sec#47/294
Op. Margin	2.02%	KR#1,381/2,421 Sec#173/294
Revenue Growth	14.42%	KR#713/2,421 Sec#68/294
Earnings Growth	293.70%	KR#169/2,421 Sec#23/294
Financial Health
Debt Ratio	101.27%	KR#1,569/2,421 Sec#201/294
Total Debt	47.82B KRW	KR#1,025/2,421 Sec#162/294
FCF	2.68B KRW	KR#1,034/2,421 Sec#122/294
Cash	35.77B KRW	KR#903/2,421 Sec#115/294
Current Ratio	1.08x	KR#1,621/2,421 Sec#203/294
Net Debt/EBITDA	13.04x	KR#1,296/2,421 Sec#164/294
Performance
1Y Return	-48.05%	KR#2,014/2,421 Sec#256/294
1M Return	-8.68%	KR#2,037/2,421 Sec#256/294
From 52W High	-52.85%	KR#1,534/2,421 Sec#214/294
1Y MDD	-58.95%	KR#1,412/2,421 Sec#213/294
Trading
Volume	71,575 shares	KR#951/2,421 Sec#90/294
Trading Value	125.9M KRW	KR#1,458/2,421 Sec#159/294
Foreign Own.	0.87%	KR#2,078/2,421 Sec#251/294
Per Share
EPS	297 KRW	KR#1,183/2,421 Sec#150/294
BPS	2,101 KRW	KR#2,048/2,421 Sec#270/294

Company Info

CEO 김의중, 김도연 (각자 대표이사)

Employees 70

Founded 2000

HQ 대전광역시 유성구, KR

Website www.genofocus.com

동사는 2000년 한국생명공학연구원 스핀오프로 설립, 2015년 코스닥 특례 상장, 2025년 에이치엘비뉴로토브를 연결 편입함. 미생물 디스플레이와 재조합 단백질 발현 기술로 반도체 수처리용 카탈라제, 락타아제 등 산업용 효소와 세라마이드 원료 파이토스핑고신 등 바이오 소재 개발·생산함. 효소 생산 전 주기 기술로 이너뷰티 및 화장품 소재로 제품 포트폴리오 확장, 친환경 바이오화학 공정 기술로 적극적 사업 다각화를 추진하고 있음. HLB제넥스는 2000년에 설립되었으며 대전광역시 유성구에 본사를 두고 있습니다.